(19)
(11) EP 2 614 369 A2

(12)

(88) Date of publication A3:
07.06.2012

(43) Date of publication:
17.07.2013 Bulletin 2013/29

(21) Application number: 11824247.8

(22) Date of filing: 12.09.2011
(51) International Patent Classification (IPC): 
G01N 33/50(2006.01)
G01N 33/53(2006.01)
C07D 473/34(2006.01)
G01N 33/68(2006.01)
A61K 38/17(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2011/051258
(87) International publication number:
WO 2012/034132 (15.03.2012 Gazette 2012/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.09.2010 US 381684 P

(71) Applicant: Epizyme, Inc.
Cambridge, MA 02139 (US)

(72) Inventors:
  • COPELAND, Robert Allen
    Lexington, MA 02421 (US)
  • RICHON, Victoria Marie
    Wellesley, MA 02481 (US)
  • SCOTT, Margaret Davis
    Beverly, MA 01915 (US)
  • SNEERINGER, Christopher John
    San Francisco, CA 94110 (US)
  • KUNTZ, Kevin Wayne
    Woburn, MA 01801 (US)
  • KNUTSON, Sarah Kathleen
    Cambridge, MA 02138 (US)
  • POLLOCK, Roy Macfarlane
    Medford, MA 02155 (US)

(74) Representative: Mintz Levin Cohn Ferris Glovsky and Popeo LLP 
Alder Castle 10 Noble Street
London EC2V 7JX
London EC2V 7JX (GB)

   


(54) INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF